CAXTON CORP - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 28 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q4 2018$318,000
-12.6%
42,236
-34.4%
0.39%
+14.9%
Q3 2018$364,000
+27.7%
64,396
-0.6%
0.34%
+232.7%
Q2 2018$285,000
-27.8%
64,817
+0.8%
0.10%
-76.5%
Q1 2018$395,000
+5.3%
64,280
-11.7%
0.43%
-5.9%
Q4 2017$375,000
-44.9%
72,782
-4.4%
0.46%
-34.2%
Q3 2017$681,00076,1390.69%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q2 2018
NameSharesValueWeighting ↓
Prosight Management, LP 815,789$3,541,0001.78%
MEITAV INVESTMENT HOUSE LTD 2,460,136$10,651,0000.71%
DAFNA Capital Management LLC 415,989$1,805,0000.68%
KNOTT DAVID M 259,377$1,126,0000.48%
SECTORAL ASSET MANAGEMENT INC 879,000$3,815,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 620,000$2,691,0000.37%
ESSEX INVESTMENT MANAGEMENT CO LLC 283,434$1,230,0000.17%
Harel Insurance Investments & Financial Services Ltd. 624,809$2,711,0000.14%
Avoro Capital Advisors LLC 820,000$3,559,0000.12%
MENTA CAPITAL LLC 52,792$229,0000.10%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders